Eli Lilly and Company (SWX:LLY)
640.00
+10.00 (1.59%)
At close: Oct 21, 2025
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $15.56B USD in the quarter ending June 30, 2025, with 37.64% growth. This brings the company's revenue in the last twelve months to $53.26B, up 36.83% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$53.26B
Revenue Growth
+36.83%
P/S Ratio
13.47
Revenue / Employee
$1.13M
Employees
47,000
Market Cap
570.42B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 63.49B |
Novartis AG | 43.89B |
Sandoz Group AG | 8.42B |
Alcon | 7.97B |
Lonza Group AG | 7.09B |
Galenica AG | 4.03B |
Sonova Holding AG | 3.87B |
Galderma Group AG | 3.73B |
Eli Lilly and Company News
- 2 days ago - Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk and J&J in focus - Seeking Alpha
- 3 days ago - Our Top 10 High Growth Dividend Stocks - October 2025 - Seeking Alpha
- 4 days ago - President Trump targets $150 MFN price for GLP-1s - CNBC
- 4 days ago - Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s - CNBC
- 4 days ago - 3 Price Catalysts For Eli Lilly - Seeking Alpha
- 4 days ago - Eli Lilly (LLY) Shares Drop Due to Recent Voucher Snub and Competitive Pricing Pressures - GuruFocus
- 4 days ago - Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks - Investopedia
- 4 days ago - Eli Lilly falls on orforglipron FDA voucher exclusion, Trump on weight-loss meds - Seeking Alpha